These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16295528)

  • 1. A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics.
    Bogdanos DP; Smith H; Ma Y; Baum H; Mieli-Vergani G; Vergani D
    Clin Dev Immunol; 2005 Sep; 12(3):217-24. PubMed ID: 16295528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis.
    Hughes LE; Smith PA; Bonell S; Natt RS; Wilson C; Rashid T; Amor S; Thompson EJ; Croker J; Ebringer A
    J Neuroimmunol; 2003 Nov; 144(1-2):105-15. PubMed ID: 14597104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice.
    Mokhtarian F; Zhang Z; Shi Y; Gonzales E; Sobel RA
    J Neuroimmunol; 1999 Mar; 95(1-2):43-54. PubMed ID: 10229114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
    Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
    J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
    Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis.
    Guggenmos J; Schubart AS; Ogg S; Andersson M; Olsson T; Mather IH; Linington C
    J Immunol; 2004 Jan; 172(1):661-8. PubMed ID: 14688379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.
    Van der Aa A; Hellings N; Bernard CC; Raus J; Stinissen P
    J Neuroimmunol; 2003 Apr; 137(1-2):164-76. PubMed ID: 12667661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
    Egg R; Reindl M; Deisenhammer F; Linington C; Berger T
    Mult Scler; 2001 Oct; 7(5):285-9. PubMed ID: 11724443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis.
    Wallström E; Khademi M; Andersson M; Weissert R; Linington C; Olsson T
    Eur J Immunol; 1998 Oct; 28(10):3329-35. PubMed ID: 9808202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.
    Rauer S; Euler B; Reindl M; Berger T
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):739-42. PubMed ID: 16705196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.
    Angelucci F; Mirabella M; Frisullo G; Caggiula M; Tonali PA; Batocchi AP
    Dis Markers; 2005; 21(2):49-55. PubMed ID: 15920290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.
    Lutterotti A; Reindl M; Gassner C; Poustka K; Schanda K; Deisenhammer F; Berger T
    J Neuroimmunol; 2002 Oct; 131(1-2):201-7. PubMed ID: 12458053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
    Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
    Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
    Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
    J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.
    Ichikawa M; Johns TG; Adelmann M; Bernard CC
    Int Immunol; 1996 Nov; 8(11):1667-74. PubMed ID: 8943561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.
    von Büdingen HC; Tanuma N; Villoslada P; Ouallet JC; Hauser SL; Genain CP
    J Clin Immunol; 2001 May; 21(3):155-70. PubMed ID: 11403222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.
    Diaz-Villoslada P; Shih A; Shao L; Genain CP; Hauser SL
    J Neuroimmunol; 1999 Sep; 99(1):36-43. PubMed ID: 10496175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.